1,1-dichloroethene decreases expression ISO RGD:1312253 6480464 vinylidene chloride results in decreased expression of OXCT1 mRNA CTD PMID:26682919 1,2-dichloroethane decreases expression ISO RGD:1312253 6480464 ethylene dichloride results in decreased expression of OXCT1 mRNA CTD PMID:28960355 1,2-dimethylhydrazine decreases expression ISO RGD:1312253 6480464 1, 2-Dimethylhydrazine results in decreased expression of OXCT1 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:1312253 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in decreased expression of OXCT1 mRNA] CTD PMID:22206623 1,3-dinitrobenzene increases oxidation EXP 6480464 3-dinitrobenzene results in increased oxidation of OXCT1 protein CTD PMID:25716674 17alpha-ethynylestradiol multiple interactions ISO RGD:1312253 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of OXCT1 mRNA CTD PMID:17942748 17alpha-ethynylestradiol affects expression ISO RGD:1312253 6480464 Ethinyl Estradiol affects the expression of OXCT1 mRNA CTD PMID:17555576 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1312253 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of OXCT1 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of OXCT1 mRNA CTD PMID:32109520 , PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1312253 6480464 Tetrachlorodibenzodioxin affects the expression of OXCT1 mRNA CTD PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of OXCT1 mRNA CTD PMID:26232522 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1312253 6480464 Tetrachlorodibenzodioxin results in increased expression of OXCT1 mRNA CTD PMID:19770486 , PMID:21496263 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1312252 6480464 Tetrachlorodibenzodioxin results in increased expression of OXCT1 mRNA CTD PMID:21496263 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1312252 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of OXCT1 mRNA CTD PMID:28628672 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of OXCT1 mRNA CTD PMID:30723492 4,4'-sulfonyldiphenol decreases methylation ISO RGD:1312253 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of OXCT1 promoter CTD PMID:33297965 4,4'-sulfonyldiphenol increases expression ISO RGD:1312252 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of OXCT1 protein CTD PMID:34186270 4,4'-sulfonyldiphenol decreases expression ISO RGD:1312253 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of OXCT1 mRNA CTD PMID:33297965 4-hydroxyphenyl retinamide decreases expression ISO RGD:1312253 6480464 Fenretinide results in decreased expression of OXCT1 mRNA CTD PMID:28973697 5-fluorouracil multiple interactions ISO RGD:1312252 6480464 TP53 protein affects the reaction [Fluorouracil results in decreased expression of OXCT1 mRNA] CTD PMID:15016801 5-fluorouracil affects response to substance ISO RGD:1312252 6480464 OXCT1 protein affects the susceptibility to Fluorouracil CTD PMID:16217747 7H-xanthine multiple interactions EXP 6480464 [Xanthine co-treated with XDH protein] results in decreased expression of OXCT1 protein CTD PMID:19464573 9H-xanthine multiple interactions EXP 6480464 [Xanthine co-treated with XDH protein] results in decreased expression of OXCT1 protein CTD PMID:19464573 acetamide increases expression EXP 6480464 acetamide results in increased expression of OXCT1 mRNA CTD PMID:31881176 acrolein multiple interactions ISO RGD:1312252 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of OXCT1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of OXCT1 mRNA CTD PMID:32699268 aflatoxin B1 decreases expression ISO RGD:1312253 6480464 Aflatoxin B1 results in decreased expression of OXCT1 mRNA CTD PMID:19770486 all-trans-retinoic acid decreases expression ISO RGD:1312252 6480464 Tretinoin results in decreased expression of OXCT1 mRNA CTD PMID:23724009 , PMID:33167477 alpha-pinene multiple interactions ISO RGD:1312252 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of OXCT1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of OXCT1 mRNA CTD PMID:32699268 amiodarone increases expression EXP 6480464 Amiodarone results in increased expression of OXCT1 mRNA CTD PMID:17991464 Aroclor 1254 decreases expression ISO RGD:1312253 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of OXCT1 mRNA CTD PMID:23650126 arsane affects methylation ISO RGD:1312252 6480464 Arsenic affects the methylation of OXCT1 gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:1312252 6480464 Arsenic affects the methylation of OXCT1 gene CTD PMID:25304211 atrazine decreases expression ISO RGD:1312252 6480464 Atrazine results in decreased expression of OXCT1 mRNA CTD PMID:22378314 benzo[a]pyrene decreases expression ISO RGD:1312252 6480464 Benzo(a)pyrene results in decreased expression of OXCT1 mRNA CTD PMID:20064835 benzo[a]pyrene increases expression ISO RGD:1312252 6480464 Benzo(a)pyrene results in increased expression of OXCT1 mRNA CTD PMID:32234424 benzo[a]pyrene decreases methylation ISO RGD:1312252 6480464 Benzo(a)pyrene results in decreased methylation of OXCT1 promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:1312253 6480464 Benzo(a)pyrene results in decreased expression of OXCT1 mRNA CTD PMID:19770486 Benzo[ghi]perylene increases expression ISO RGD:1312253 6480464 1, 12-benzoperylene results in increased expression of OXCT1 mRNA CTD PMID:26377693 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of OXCT1 mRNA CTD PMID:25181051 bisphenol A decreases methylation ISO RGD:1312252 6480464 bisphenol A results in decreased methylation of OXCT1 gene CTD PMID:31601247 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of OXCT1 mRNA CTD PMID:34947998 bisphenol A decreases expression ISO RGD:1312252 6480464 bisphenol A results in decreased expression of OXCT1 mRNA, bisphenol A results in decreased expression of OXCT1 protein CTD PMID:29275510 , PMID:34186270 bisphenol A multiple interactions ISO RGD:1312252 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of OXCT1 mRNA CTD PMID:28628672 Bisphenol B increases expression ISO RGD:1312252 6480464 bisphenol B results in increased expression of OXCT1 protein CTD PMID:34186270 bisphenol F increases expression ISO RGD:1312252 6480464 bisphenol F results in increased expression of OXCT1 protein CTD PMID:34186270 bromobenzene decreases expression EXP 6480464 bromobenzene results in decreased expression of OXCT1 mRNA CTD PMID:15056800 butanal increases expression ISO RGD:1312252 6480464 butyraldehyde results in increased expression of OXCT1 mRNA CTD PMID:26079696 cadmium atom multiple interactions ISO RGD:1312252 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of OXCT1 mRNA CTD PMID:35301059 cadmium dichloride multiple interactions ISO RGD:1312252 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of OXCT1 mRNA CTD PMID:35301059 captan increases expression ISO RGD:1312253 6480464 Captan results in increased expression of OXCT1 mRNA CTD PMID:31558096 carbon nanotube decreases expression ISO RGD:1312253 6480464 Nanotubes more ... CTD PMID:25554681 CGP 52608 multiple interactions ISO RGD:1312252 6480464 CGP 52608 promotes the reaction [RORA protein binds to OXCT1 gene] CTD PMID:28238834 chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of OXCT1 mRNA CTD PMID:20691718 choline multiple interactions ISO RGD:1312253 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of OXCT1 mRNA CTD PMID:20938992 chromium(6+) affects expression ISO RGD:1312253 6480464 chromium hexavalent ion affects the expression of OXCT1 mRNA CTD PMID:28472532 ciguatoxin CTX1B affects expression ISO RGD:1312253 6480464 Ciguatoxins affects the expression of OXCT1 mRNA CTD PMID:18353800 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of OXCT1 mRNA CTD PMID:22023808 cisplatin multiple interactions ISO RGD:1312252 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of OXCT1 mRNA CTD PMID:27392435 cisplatin decreases expression ISO RGD:1312252 6480464 Cisplatin results in decreased expression of OXCT1 mRNA CTD PMID:27392435 cisplatin increases expression ISO RGD:1312252 6480464 Cisplatin results in increased expression of OXCT1 mRNA CTD PMID:27594783 cisplatin multiple interactions ISO RGD:1312253 6480464 [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in decreased expression of OXCT1 mRNA CTD PMID:23625948 cobalt dichloride decreases expression ISO RGD:1312252 6480464 cobaltous chloride results in decreased expression of OXCT1 mRNA CTD PMID:19320972 coumestrol increases expression ISO RGD:1312252 6480464 Coumestrol results in increased expression of OXCT1 mRNA CTD PMID:19167446 coumestrol multiple interactions ISO RGD:1312252 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 cyclosporin A decreases expression ISO RGD:1312253 6480464 Cyclosporine results in decreased expression of OXCT1 mRNA CTD PMID:19770486 cyclosporin A decreases expression ISO RGD:1312252 6480464 Cyclosporine results in decreased expression of OXCT1 mRNA CTD PMID:27989131 dexamethasone multiple interactions ISO RGD:1312252 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of OXCT1 mRNA CTD PMID:28628672 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of OXCT1 mRNA CTD PMID:21266533 dibutyl phthalate increases expression ISO RGD:1312253 6480464 Dibutyl Phthalate results in increased expression of OXCT1 mRNA CTD PMID:21266533 diuron decreases expression ISO RGD:1312252 6480464 Diuron metabolite results in decreased expression of OXCT1 mRNA CTD PMID:24172598 doxorubicin decreases expression ISO RGD:1312253 6480464 Doxorubicin results in decreased expression of OXCT1 mRNA CTD PMID:26873546 doxorubicin increases expression ISO RGD:1312252 6480464 Doxorubicin results in increased expression of OXCT1 mRNA CTD PMID:29803840 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of OXCT1 mRNA CTD PMID:29391264 Enterolactone multiple interactions ISO RGD:1312252 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of OXCT1 mRNA CTD PMID:19167446 ethanol multiple interactions ISO RGD:1312253 6480464 Ethanol affects the expression of and affects the splicing of OXCT1 mRNA CTD PMID:30319688 folic acid multiple interactions ISO RGD:1312253 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of OXCT1 mRNA more ... CTD PMID:20938992 , PMID:22206623 folpet increases expression ISO RGD:1312253 6480464 folpet results in increased expression of OXCT1 mRNA CTD PMID:31558096 fonofos increases methylation ISO RGD:1312252 6480464 Fonofos results in increased methylation of OXCT1 promoter CTD PMID:22847954 formaldehyde decreases expression ISO RGD:1312252 6480464 Formaldehyde results in decreased expression of OXCT1 mRNA CTD PMID:23649840 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of OXCT1 mRNA CTD PMID:22061828 , PMID:33387578 hydrogen sulfide increases expression ISO RGD:1312253 6480464 Hydrogen Sulfide results in increased expression of OXCT1 protein CTD PMID:29932956 indometacin multiple interactions ISO RGD:1312252 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of OXCT1 mRNA CTD PMID:28628672 ivermectin decreases expression ISO RGD:1312252 6480464 Ivermectin results in decreased expression of OXCT1 protein CTD PMID:32959892 L-methionine multiple interactions ISO RGD:1312253 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of OXCT1 mRNA CTD PMID:20938992 methotrexate decreases expression ISO RGD:1312252 6480464 Methotrexate results in decreased expression of OXCT1 mRNA CTD PMID:24449571 mitoxantrone affects response to substance ISO RGD:1312252 6480464 OXCT1 protein affects the susceptibility to Mitoxantrone CTD PMID:16217747 mono(2-ethylhexyl) phthalate affects expression ISO RGD:1312253 6480464 mono-(2-ethylhexyl)phthalate affects the expression of OXCT1 mRNA CTD PMID:21195148 Monobutylphthalate affects expression ISO RGD:1312253 6480464 monobutyl phthalate affects the expression of OXCT1 mRNA CTD PMID:21195148 morphine decreases expression EXP 6480464 Morphine results in decreased expression of OXCT1 protein CTD PMID:23056601 N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of OXCT1 mRNA CTD PMID:28801915 nickel sulfate decreases expression ISO RGD:1312252 6480464 nickel sulfate results in decreased expression of OXCT1 mRNA CTD PMID:16780908 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of OXCT1 mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:1312252 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of OXCT1 mRNA more ... CTD PMID:32699268 paracetamol decreases expression ISO RGD:1312252 6480464 Acetaminophen results in decreased expression of OXCT1 mRNA CTD PMID:25704631 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of OXCT1 mRNA CTD PMID:33387578 parathion increases methylation ISO RGD:1312252 6480464 Parathion results in increased methylation of OXCT1 promoter CTD PMID:22847954 pentanal increases expression ISO RGD:1312252 6480464 pentanal results in increased expression of OXCT1 mRNA CTD PMID:26079696 PhIP increases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in increased expression of OXCT1 mRNA CTD PMID:33945839 picoxystrobin decreases expression ISO RGD:1312252 6480464 picoxystrobin results in decreased expression of OXCT1 mRNA CTD PMID:33512557 pirinixic acid multiple interactions ISO RGD:1312253 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of OXCT1 mRNA CTD PMID:19710929 pirinixic acid decreases expression ISO RGD:1312253 6480464 pirinixic acid results in decreased expression of OXCT1 mRNA CTD PMID:17426115 , PMID:18445702 propanal increases expression ISO RGD:1312252 6480464 propionaldehyde results in increased expression of OXCT1 mRNA CTD PMID:26079696 resveratrol multiple interactions ISO RGD:1312252 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of OXCT1 mRNA CTD PMID:19167446 rotenone decreases expression ISO RGD:1312252 6480464 Rotenone results in decreased expression of OXCT1 mRNA CTD PMID:33512557 rotenone increases expression EXP 6480464 Rotenone results in increased expression of OXCT1 protein CTD PMID:35544339 silicon dioxide increases expression ISO RGD:1312252 6480464 Silicon Dioxide analog results in increased expression of OXCT1 mRNA CTD PMID:25895662 sodium arsenate increases expression ISO RGD:1312253 6480464 sodium arsenate results in increased expression of OXCT1 mRNA CTD PMID:21795629 sodium arsenite increases expression ISO RGD:1312253 6480464 sodium arsenite results in increased expression of OXCT1 protein CTD PMID:29044176 sodium arsenite increases expression ISO RGD:1312252 6480464 sodium arsenite results in increased expression of OXCT1 mRNA CTD PMID:29301061 sodium dichromate increases expression ISO RGD:1312253 6480464 sodium bichromate results in increased expression of OXCT1 mRNA CTD PMID:31558096 tamoxifen multiple interactions EXP 6480464 [Tamoxifen results in increased activity of NOA1 protein] which results in decreased activity of OXCT1 protein CTD PMID:17283165 temozolomide decreases expression ISO RGD:1312252 6480464 Temozolomide results in decreased expression of OXCT1 mRNA CTD PMID:31758290 terbufos increases methylation ISO RGD:1312252 6480464 terbufos results in increased methylation of OXCT1 promoter CTD PMID:22847954 testosterone decreases expression ISO RGD:1312253 6480464 Testosterone results in decreased expression of OXCT1 mRNA CTD PMID:20403060 testosterone increases expression ISO RGD:1312253 6480464 Testosterone deficiency results in increased expression of OXCT1 mRNA CTD PMID:33848595 testosterone multiple interactions ISO RGD:1312253 6480464 1 more ... CTD PMID:33848595 tetrachloromethane increases expression ISO RGD:1312253 6480464 Carbon Tetrachloride results in increased expression of OXCT1 mRNA CTD PMID:27339419 , PMID:31919559 thiabendazole affects expression EXP 6480464 Thiabendazole affects the expression of OXCT1 mRNA CTD PMID:18539377 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of OXCT1 mRNA CTD PMID:34492290 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of OXCT1 mRNA CTD PMID:25729387 tributylstannane increases expression ISO RGD:1312253 6480464 tributyltin results in increased expression of OXCT1 mRNA CTD PMID:31939706 trichloroethene affects expression ISO RGD:1312253 6480464 Trichloroethylene affects the expression of OXCT1 mRNA CTD PMID:21135412 triclosan increases expression ISO RGD:1312252 6480464 Triclosan results in increased expression of OXCT1 mRNA CTD PMID:30510588 valproic acid increases expression ISO RGD:1312252 6480464 Valproic Acid results in increased expression of OXCT1 mRNA CTD PMID:29154799 valproic acid increases methylation ISO RGD:1312252 6480464 Valproic Acid results in increased methylation of OXCT1 gene CTD PMID:29154799 vancomycin increases expression ISO RGD:1312253 6480464 Vancomycin results in increased expression of OXCT1 mRNA CTD PMID:18930951
